Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Share News (INDV)

Share Price Information for Indivior (INDV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,773.00
Bid: 1,461.00
Ask: 1,430.00
Change: 328.00 (22.70%)
Spread: -31.00 (-2.122%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,445.00
INDV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: Muted Friday Unable To Dent Positive Week

Fri, 27th Nov 2020 17:03

(Alliance News) - Stocks in London limped to a lacklustre end to the week on Friday, with AstraZeneca's potential coronavirus vaccine coming under increased scrutiny.

The UK government said it has asked its independent medicines regulator to assess AstraZeneca's vaccine as part of the formal approval process for the drug to be rolled out by the end of the year.

AstraZeneca has completed phase 3 clinical trials of its vaccine, the last stage before regulatory approval. But under British rules, the government must also ask the independent Medicines & Healthcare products Regulatory Agency to green light the drug.

Astra added 0.4% Friday.

On Thursday, the head of British drug manufacturer AstraZeneca said further research was needed on its Covid-19 vaccine after questions emerged over the protection it could offer.

"Now that we've found what looks like a better efficacy we have to validate this, so we need to do an additional study," Chief Executive Pascal Soriot told Bloomberg in an interview.

The FTSE 100 index added 4.65 points, or 0.1%, at 6,367.58. The large-cap index added 0.6 % this week.

The mid-cap FTSE 250 index gained 66.37 points, or 0.3%, at 19,462.71. The AIM All-Share index ended slightly higher, gaining 0.98 of a point, at 1,039.01.

The Cboe UK 100 index closed 0.1% higher at 634.21. The Cboe 250 closed down 1.0% at 16,581.96. The Cboe Small Companies ended down 1.5% at 11,276.56.

"As the final full week of November trading winds down we find markets still in a guardedly-positive mood. It has been a great month, continuing of course the strong run since March for many markets, and while it might not be going out on a high there is still no sign of any correction on the horizon," IG's Chief Market Analyst Chris Beauchamp said.

He continued: "However, high sentiment and breadth readings should give investors pause, with a legitimate question being how much of the expected December gain has been pulled forward into the preceding month. While election concerns seem to have almost entirely disappeared, and rightly so given Trump's comments about making way for the new administration, the virus situation remains, and still has the power to shock should the Thanksgiving holiday produce another surge in US cases."

UK stocks were underperforming those in in mainland Europe. The CAC 40 in Paris and the DAX 30 in Frankfurt advanced 0.6% and 0.4%, respectively.

"The difference between the FTSE and its Western peers is the underlying Brexit talk anxieties that are only going to become more pronounced in the coming days and weeks - and sent the pound 0.3% lower against the euro - and fears that the Oxford/AstraZeneca vaccine might not be quite as effective as first claimed," SpreadEx analyst Connor Campbell.

A Brexit deal is still possible, the UK's chief negotiator has insisted as face-to-face negotiations are set to resume with the clock ticking down to an agreement deadline.

But David Frost warned that a deal is only possible if Brussels recognised British sovereignty in key areas.

Frost was speaking ahead of face-to-face talks, which he said would take place on Saturday.

The comments came after EU chief negotiator Michel Barnier warned that "significant divergences" still remain ahead of the UK exiting the Brexit transition period at the end of December.

The pound was quoted at USD1.3331 on Friday evening, broadly flat from USD1.3333 at the London equities close Thursday.

The euro stood at USD1.1957, up from USD1.1908. Against the Japanese yen, the dollar was trading at JPY103.99, down from JPY104.27.

Wall Street was painted green on Friday's half-day, with the Dow Jones Industrial Average up 0.1%, the S&P 500 up 0.3% and the Nasdaq Composite up 1.1%.

Financial markets in the US reopened for a half-day on Friday after being closed on Thursday for Thanksgiving.

In London, Homserve gave back 1.3%. The home emergency cover provider finds itself on the brink of automatic demotion from the large-cap index ahead of the FTSE Russell index review changes next week. Homeserve currently ranks 115th in the FTSE 350 by market capitalisation, just below the safety threshold at 110th place, with a total market value of GBP3.4 billion.

In the FTSE 250, Indivior was the worst performer, closing down 20% after the drugmaker said Reckitt Benckiser has submitted a GBP1.07 billion claim against the company.

The claim related to an indemnity contained in the demerger agreement entered into between the two companies in November 2014. Indivior spun off from consumer health and hygiene firm Reckitt and listed on the London Stock Exchange in December of that year.

The claim was submitted on November 13.

Indivior said: "The claim has not been served on the company and the company does not have any further details at this time. The company will assess with its advisors the background and merits to the case and will provide an update in due course."

Reckitt lost 1.3% Friday.

JD Wetherspoon bounced back in afternoon trade, gaining 1.2%, despite opening down 4.9%. The pub chain complained bitterly about the UK government's post-lockdown tier system, which effectively forces almost half of its about 870 pubs to close.

Just 13 Wetherspoon pubs in England are in areas classified as Tier 1, under the new UK virus restrictions that go into place from next week. In addition, there are 51 pubs in Wales, where the regulations equate to Tier 1 in England.

In Tier 1, the rule of six applies indoors and outdoors, but in Tier 2 there will be a ban on households mixing indoors, and pubs and restaurants will only be able to sell alcohol with a "substantial meal". Tier 3 measures mean a ban on households mixing, except in limited circumstances such as in parks.

For Wetherspoon, Tier 2 affects 435 pubs. This tier includes 17 pubs in Scotland where the regulations approximate to Tier 2 in England, the pub chain said.

"These rules greatly reduced pub capacity and provided strict social distancing and hygiene standards but, with difficultly, allowed pubs to trade viably. It is very disappointing that yet another raft of regulations has been introduced, which has effectively closed half our pubs," said Chair Tim Martin.

Brent oil was trading at USD48.05 a barrel Friday evening, up from USD47.77 late Thursday. Gold fetched USD1,786.40 an ounce, lower from USD1,810.32.

A busy global economic calendar next week is headlined by US Fed Chair Jerome Powell testifying before Congress on Tuesday and US non-farm payrolls and unemployment on Friday.

On Monday, there is China non-manufacturing PMI overnight and German consumer price index at 1300 GMT. There is a slew of manufacturing manufacturing PMIs, with Japan and China overnight, followed by Germany, eurozone, and UK at 0855 GMT, 0900 GMT and 0930 GMT, respectively. US Markit manufacturing is due 1445 GMT.

On Thursday, there will be a run of service PMI readings, with China and Japan overnight, then Germany, eurozone and UK at 0855 GMT, 0900 GMT and 0930 GMT, respectively. US ISM services at 1500 GMT.

The local corporate calendar on Monday has half-year results from electronic parts supplier discoverIE Group, carpet designer Victoria, venture capital firm Draper Esprit, and social housing investor Civitas Social Housing.

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
21 Aug 2023 07:23

Indivior settles part of US suboxone litigation

(Sharecast News) - Addiction treatment specialist Indivior announced on Monday that its US subsidiary has entered into an agreement to settle the claims initiated by the end payor class in the ongoing multi-district suboxone antitrust litigation.

Read more
1 Aug 2023 17:39

TRADING UPDATES: C4X Discovery inks Indivior deal, Digitalbox expands

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
28 Jul 2023 09:46

LONDON BROKER RATINGS: KBW cuts Aviva 'market perform'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
27 Jul 2023 11:48

Indivior raises 2023 guidance after strong half-year progress

(Alliance News) - Indivior PLC on Thursday celebrated a strong recent six months and second quarter that brough increased profit and revenue, boosting its optimism for the rest of the year.

Read more
27 Jul 2023 10:04

Indivior lifts guidance after strong first half

(Sharecast News) - Pharmaceuticals firm Indivior reported a 24% improvement in net revenue in its half-year report on Thursday, to $529m.

Read more
12 Jun 2023 07:53

LONDON BRIEFING: Shares on the rise; Frasers buys into AO World

(Alliance News) - Stocks in London were set to open higher on Monday, at the start of a busy week of central bank moves.

Read more
5 Jun 2023 07:46

Indivior reaches settlement in litigation with US states

(Sharecast News) - Addiction treatment-focussed pharmaceuticals company Indivior announced on Monday that its subsidiary Indivior Inc has successfully reached an agreement to resolve the claims brought against it by the attorneys general of 41 US states and the District of Columbia.

Read more
2 Jun 2023 18:18

Indivior settles antitrust claims in US regarding Suboxone drug

(Alliance News) - Indivior PLC on Friday said it has reached an agreement to resolve the claims brought in antitrust multi-district litigation regarding its drug Suboxone.

Read more
25 May 2023 09:23

LONDON BROKER RATINGS: Numis starts Tristel with 'add'

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
23 May 2023 09:56

Indivior emergency opioid overdose treatment approved by US FDA

(Alliance News) - Indivior PLC on Tuesday said the US Food & Drug Administration has approved its OPVEE nasal spray for the emergency treatment of opioid overdose.

Read more
23 May 2023 07:48

Indivior's opioid addiction sprat approved by FDA

(Sharecast News) - US health regulators have approved Indivior's Opvee nasal spray treatment for opiod addiction, the company said on Tuesday.

Read more
10 May 2023 17:02

DIRECTOR DEALINGS: Indivior division chief sells GBP1.7 million shares

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Wednesday and not separately reported by Alliance News:

Read more
27 Apr 2023 15:49

UK shareholder meetings calendar - next 7 days

Friday 28 April 
AQRU PLCAGM
Audioboom Group PLCAGM
BBGI Global Infrastructure SAAGM
Everest Global PLCAGM
GetBusy PLCAGM
Greencoat Renewables PLCAGM
Greencoat UK Wind PLCAGM
Hikma Pharmaceuticals PLCAGM
JPMorgan Claverhouse Investment Trust PLCAGM
Kingspan Group PLCAGM
ME Group International PLCAGM
Minoan Group PLCAGM
Pearson PLCAGM
Rotork PLCAGM
Shanta Gold LtdAGM
Smurfit Kappa Group PLCAGM
Symphony International Holdings LtdAGM
Monday 1 May 
no events scheduled 
Tuesday 2 May 
Carr's Group PLCGM re annual report and directors remuneration report
CVC Income & Growth LtdAGM
IOG PLCAGM
Ocado Group PLCAGM
Plus500 LtdAGM
Wednesday 3 May 
Apax Global Alpha LtdAGM
Barclays PLCAGM
GSK PLCAGM
Hyve Group PLCCourt Meeting & GM re acquisition by Heron UK Bidco Ltd
Logistics Development Group PLCAGM
Okyo Pharma LtdGM re proposed cancellation of the ordinary shares of no par value
Reach PLCAGM
Reckitt Benckiser Group PLCAGM
Standard Chartered PLCAGM
Tritax Big Box REIT PLCAGM
Unilever PLCAGM
Thursday 4 May 
AIB Group PLCAGM
Aviva PLCAGM
Aviva PLCGM re capital reduction
BAE Systems PLCAGM
Bivictrix Therapeutics PLCAGM
Domino's Pizza Group PLCAGM
Glanbia PLCAGM
Grafton Group PLCAGM
Hammerson PLCAGM
Howden Joinery Group PLCAGM
Hurricane Energy PLCCourt Meeting & GM re takeover by Prax Exploration & Production PLC  
Indivior PLCAGM
IMI PLCAGM
Irish Residential Properties REIT PLCAGM
ITV PLCAGM
Jardine Matheson Holdings LtdAGM
Johnson Service Group PLCAGM
LungLife AI IncAGM
Mincon Group PLCAGM
Mondi PLCAGM
Moneysupermarket.com Group PLCAGM
Morgan Sindall Group PLCAGM
Spirent Communications PLCAGM
Personal Group Holdings PLCAGM
Phoenix Group Holdings PLCAGM
Rathbones Group PLCAGM
SIG PLCAGM
Ten Entertainment Group PLCAGM
Travis Perkins PLCAGM
Witan Investment Trust PLCAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
27 Apr 2023 14:41

Indivior lifts revenue guidance, cuts profit outlook after Opiant deal

(Sharecast News) - Opioid addiction treatment maker Indivior lifted its full-year revenue guidance on Thursday but trimmed its outlook for operating profit due to costs related to the acquisition of Opiant Pharmaceuticals, as it posted a jump in first-quarter profit and revenue.

Read more
27 Apr 2023 13:46

Indivior raises 2023 revenue forecast following Opiant acquisition

(Alliance News) - Indivior PLC on Thursday said net revenue increased by more than 20% in the first quarter, lifting profit, and it updated its guidance for the year following its acquisition of Opiant Pharmaceuticals Inc last month.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.